A recent study by the University of Turku and the University of Helsinki in Finland and the Finnish Social Insurance Institution Kela reveals that the average duration of ADHD medication for children and adolescents is more than three years. However, reliable, controlled data on the safety of marketed ADHD medicines in children are available for only one year of follow-up.
Researchers of the University of Turku have participated in a study in which vaccinating women with acellular pertussis vaccine in pregnancy boosted the quantity and quality of pertussis-specific antibodies in the early life of infants.
Students graduating this spring from the Degree Programme in Biomedicine at the Faculty of Medicine of the University of Turku will present their Bachelor’s theses at the Terveydeksi - New Discoveries 2025! thesis seminar. In addition, students from the Drug Discovery and Development and Biomedical Imaging tracks of the Biomedical Sciences Master's programme and students from the Human Neuroscience Master's programme will present their Master's theses at the seminar. Some of the Biomedical Imaging students are from Åbo Akademi University.
A multicentre study led from Finland has shown that lymph node transfer is a viable treatment for the swelling in the affected limb, a condition known as lymphedema, after breast cancer surgery. However, an effective drug to improve the outcomes of the transfer treatment continues to be sought.
The European Commission has appointed a European Reference Laboratory to support the control and monitoring of pertussis and diphtheria in the EU/EEA countries. The University of Turku will lead and coordinate the laboratory, which includes five institutes in four countries.
How can sensitive health data be used responsibly in scientific research or how can artificial intelligence help make breakthroughs in medical research? The ECCB2024 conference brings together current themes in computational biology and international researchers in Turku, Finland.